Epilogue: Different approaches for prostate cancer screening in the EU?

European Journal of Cancer

Volumn 46, Issue 17, 2010, Pages 3120-3125

  Schröder, Fritz H ^a   Denis, Louis ^b   Roobol, Monique J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Oncology Centre of Antwerp   (Belgium)

Author keywords

Prostrate cancer; Screening

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; BELGIUM; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; DIAGNOSTIC VALUE; EUROPE; FINLAND; FRANCE; GEOGRAPHY; HUMAN; ITALY; NETHERLANDS; PATIENT ATTITUDE; PREVALENCE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; SPAIN; SWEDEN; SWITZERLAND;

AGED; ATTITUDE TO HEALTH; BIOPSY; EARLY DETECTION OF CANCER; EUROPE; EUROPEAN UNION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MORTALITY; MULTICENTER STUDIES AS TOPIC; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESIDENCE CHARACTERISTICS; RISK ASSESSMENT;

EID: 78049485886     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2010.09.038     Document Type: Article

References (20)

1. J. Ferlay, D.M. Parkin, and E. Steliarova-Foucher Estimates of cancer incidence and mortality in Europe in 2008 Eur J Cancer 46 4 2010 765 781 [Epub 2010 Jan 29]
2. Ciatto BJUI, 2003 on opportunistic screening.
3. C. Bouchardy, G. Fioretta, and E. Rapiti Recent trends in prostate cancer mortality show a continuous decrease in several countries Int J Cancer 123 2008 421 429
4. R. Kvle, A. Auvinen, and H.O. Adami Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries J Natl Cancer Inst 99 2007 1881 1887
5. R. Etzioni, K.M. Berry, J.M. Legler, and P. Shaw Prostate-specific antigen testing in black and white men: an analysis of medicare claims from 1991 to 1998 Urology 59 2 2002 251 255
6. G. Lu-Yao, T.A. Stukel, and S.L. Yao Prostate-specific antigen screening in elderly men J Natl Cancer Inst 95 23 2003 1792 1797
7. S.M. Enger, S.K. Van den Eeden, and B. Sternfeld BMC Public Health 6 2006 172
8. Website Centraal Bureau voor de Statistiek - www.cbs.nl.
9. R. Etzioni, A. Tsodikov, and A. Mariotto Quantifying the role of PSA screening in the US prostate cancer mortality decline Cancer Causes Contr 19 2 2008 175 181 [Epub 2007 Nov 20]
10. P.C. Walsh, A.W. Partin, and J.I. Epstein Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 years J Urol 152 (5 Pt 2) 1994 1831 1836
11. M. Bolla, D. Gonzalez, and P. Warde Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin N Engl J Med 337 5 1997 295 300
12. E.A. Platz, M.F. Leitzmann, and K. Visvanathan Statin drugs and risk of advanced prostate cancer J Natl Cancer Inst 98 24 2006 1819 1825
13. W.J. Catalona, D.S. Smith, and T.L. Ratliff Measurement of prostate-specific antigen in serum as a screening test for prostate cancer N Engl J Med 324 17 1991 1156 1161
14. R. Etzioni, J.M. Legler, and E.J. Feuer Cancer surveillance series: interpreting trends in prostate cancer - part III: quantifying the link between population prostate-specific antigen testing and recent declines in prostate cancer mortality J Natl Cancer Inst 91 1991 1033 1039
15. [For the ERSPC investigators] F.H. Schröder, J. Hugosson, and M.J. Roobol Screening and prostate-cancer mortality in a randomized European study N Engl J Med 360 13 2009 1320 1328
16. H.J. De Koning, H.K. Liem, and C.A. Baan Prostate cancer mortality reduction by screening: power and time frame with complete enrollment in the European Randomized study of Screening for Prostate Cancer (ERSPC) trial Int J Cancer 98 2002 268 273
17. J. Cuzick, R. Edwards, and N. Segnan Adjusting for non-compliance and contamination in randomized clinical trials Stat Med 16 9 1997 1017 1029
18. M.J. Roobol, M. Kerkhof, and F.H. Schröder Prostate cancer mortality reduction by PSA based screening adjusted for non-attendance and contamination in the European Randomized study of Screening for Prostate Cancer (ERSPC) Eur Urol 56 4 2009 584 591
19. K. Ito, R. Raaijmakers, and M. Roobol Prostate carcinoma detection and increased prostate-specific antigen levels after 4 years in Dutch and Japanese males who had no evidence of disease at initial screening Cancer 103 2 2005 242 250
20. E.A.M. Heijnsdijk, A. der Kinderen, and E.M. Wever Overdetection, overtreatment and costs in prostate-specific antigen screening for prostate cancer Br J Cancer 101 11 2009 1833 1838